OKT3 VS FK-506 RESCUE MANAGEMENT OF ACUTE STEROID-RESISTANT AND CHRONIC REJECTION

被引：0
|
作者：
PLATZ, KP
MUELLER, AR
ZYTOWSKI, M
BECHSTEIN, WO
BLUMHARDT, G
LOBECK, H
NEUHAUS, P
机构：
[1] FREE UNIV BERLIN,DEPT SURG,W-1000 BERLIN,GERMANY
[2] FREE UNIV BERLIN,DEPT PATHOL,W-1000 BERLIN,GERMANY
来源：
TRANSPLANTATION PROCEEDINGS | 1995年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1111 / 1113
页数：3
相关论文
共 50 条
  • [41] OKT3 for steroid-resistant acute GvHD: A three-center experience.
    Hebart, H
    Gscheidle, H
    Holler, E
    Niederwieser, D
    Kolb, HJ
    Kanz, L
    Einsele, H
    BLOOD, 1998, 92 (10) : 451A - 451A
  • [42] Short and long-term outcome of renal transplant recipients with steroid-resistant acute rejection treated with OKT3
    Franco, A
    Jiménez, L
    Sánchez, R
    Antolín, A
    Trigueros, M
    Aranda, I
    Gil, MT
    Olivares, J
    NEFROLOGIA, 1998, 18 (06): : 487 - 493
  • [43] OKT3 for steroid-resistant acute GvHD: A three-center experience.
    Hebart, H
    Gscheidle, H
    Holler, E
    Niederwieser, D
    Kolb, HJ
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S92 - S92
  • [44] LONG-TERM OUTCOME OF THE USE OF OKT3 TO TREAT STEROID-RESISTANT ACUTE RENAL-ALLOGRAFT REJECTION
    ROWE, PA
    FAN, KS
    GARDINER, DS
    MACPHERSON, SG
    BRADLEY, JA
    RODGER, RSC
    JUNOR, BJR
    BRIGGS, JD
    TRANSPLANT INTERNATIONAL, 1994, 7 (04) : 278 - 283
  • [45] Comparison of tacrolimus and OKT3 treatment of steroid-resistant acute hepatic allograft rejection in children GE loss.
    Thistlethwaite, JR
    Grewal, HP
    Bruce, D
    Cronin, D
    Whitington, PF
    Newell, K
    Kelly, S
    Alonso, E
    Oswald, K
    Woodle, ES
    Millis, JM
    HEPATOLOGY, 1997, 26 (04) : 424 - 424
  • [46] FK-506 RESCUE THERAPY FOR REFRACTORY ACUTE REJECTION IN 5 LIVER RECIPIENTS
    RUCAY, P
    SAMUEL, D
    GILLET, D
    BISMUTH, H
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3000 - 3001
  • [47] COMPARISON OF FK-506-BASED AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION - FK-506 THERAPY SIGNIFICANTLY REDUCES THE INCIDENCE OF ACUTE, STEROID-RESISTANT, REFRACTORY, AND CHRONIC REJECTION WHILE POSSESSING A COMPARABLE SAFETY PROFILE
    BISMUTH, H
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 45 - 49
  • [48] INCREASED INFECTIONS ASSOCIATED WITH THE USE OF OKT3 FOR TREATMENT OF STEROID-RESISTANT REJECTION IN RENAL-TRANSPLANTATION
    OH, CS
    STRATTA, RJ
    FOX, BC
    SOLLINGER, HW
    BELZER, FO
    MAKI, DG
    TRANSPLANTATION, 1988, 45 (01) : 68 - 73
  • [49] FK-506 RESCUE THERAPY FOR RESISTANT REJECTION EPISODES IN LIVER-TRANSPLANT RECIPIENTS
    DALESSANDRO, AM
    KALAYOGLU, M
    PIRSCH, JD
    CORWITH, C
    KNECHTLE, SJ
    REED, A
    BELZER, FO
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2987 - 2988
  • [50] THE COMPLICATIONS OF NEWER TRANSPLANT ANTIREJECTION DRUGS - TREATMENT WITH CYCLOSPORINE-A, OKT3, AND FK-506
    LI, PKT
    NICHOLLS, MG
    LAI, KN
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1990, 9 (03): : 123 - 155
12345